The non-insulin diabetes therapeutics market is poised to grow by USD 22.95 billion during 2021-2025, progressing at a CAGR of over 10% during the forecast period.
Technavio's in-depth market research reports include value chain analysis and validation techniques to help industry leaders improve their business. Download FREE Sample Report
The report on the non-insulin diabetes therapeutics market provides a holistic update, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis.
The report offers an up-to-date analysis regarding the current global market scenario and the overall market environment. The market is driven by factors such as the increasing number of people with type 2 diabetes, the growing prevalence of diabetes among people aged 6-19 and 35-50, and the recent product approvals.
The non-insulin diabetes therapeutics market analysis includes type and geography landscape segments. This study identifies the recent product approvals as one of the prime reasons driving the non-insulin diabetes therapeutics market growth during the next few years.
This report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.
The non-insulin diabetes therapeutics market covers the following areas:
Global Type 1 Diabetes Drugs Market- The type 1 diabetes drugs market is segmented by product (long-acting insulins, rapid-acting insulins, premixed insulins, and non-insulin drugs) and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
Global Type 2 Diabetes Market- The type 2 diabetes market is segmented by drug class (insulin, DPP-4 inhibitors, GLP-1 receptor agonists, SGLT-2 inhibitors, and others) and geography (North America, Europe, Asia, and ROW). Download FREE Sample Report
Key Topics Covered:
Value chain analysis
Market segment analysis
Market size 2020
Market outlook: Forecast for 2020- 2025
Five Forces Analysis
Five forces summary
Bargaining power of buyers
Bargaining power of suppliers
Threat of new entrants
Threat of substitutes
Threat of rivalry
Market Segmentation by Type
Comparison by Type
DPP4 inhibitor - Market size and forecast 2020-2025
GLP-1 receptor agonist - Market size and forecast 2020-2025
SGLT2 inhibitor - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
Market opportunity by Type
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market positioning of vendors
Eli Lilly and Co.
F. Hoffmann-La Roche Ltd.
Johnson and Johnson
Novo Nordisk AS
Scope of the report
Currency conversion rates for US$
List of abbreviations
About Us Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.